JEREMY BICKETT: Open Payments
NPI 1770689150 · SPRINGBORO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 95 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,405 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 65 | $720 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $245 |
| Novo Nordisk Inc | 15 | $159 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, QULIPTA, Ozempic, UBRELVY, CREON, RECORLEV, MOUNJARO.
Industry payments across OH — which companies pay providers there.
